Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Neuroendocrine Tumors in Lung
×
lanreotide
×
Clear all
Filters
3
NCT02683941
2022-07-06
SPINET
Ipsen
Phase 3
Terminated
77 enrolled
20 charts